Victrex (LON:VCT – Get Free Report)‘s stock had its “hold” rating reissued by stock analysts at Jefferies Financial Group in a research report issued on Tuesday,London Stock Exchange reports. They presently have a GBX 595 target price on the stock. Jefferies Financial Group’s target price would indicate a potential downside of 13.93% from the company’s current price.
A number of other equities analysts have also recently commented on VCT. Berenberg Bank reduced their target price on Victrex from GBX 695 to GBX 600 and set a “hold” rating for the company in a report on Tuesday, June 9th. Canaccord Genuity Group downgraded shares of Victrex to a “buy” rating and set a GBX 725 price target on the stock. in a research note on Friday, May 15th. UBS Group restated a “sell” rating and set a GBX 575 price target on shares of Victrex in a research report on Monday, May 11th. Finally, JPMorgan Chase & Co. dropped their price target on Victrex from GBX 725 to GBX 625 and set a “buy” rating for the company in a research report on Wednesday, March 18th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of GBX 662.86.
Get Our Latest Research Report on Victrex
Victrex Stock Performance
Victrex (LON:VCT – Get Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported GBX 17.20 EPS for the quarter. Victrex had a negative return on equity of 4.95% and a negative net margin of 6.70%.The business had revenue of £147.10 million for the quarter. On average, sell-side analysts forecast that Victrex will post 73.1078905 earnings per share for the current year.
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Read More
- Five stocks we like better than Victrex
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
- Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
